No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer Review uri icon

Overview

MeSH Major

  • Breast Neoplasms
  • Neoplasms, Glandular and Epithelial
  • Ovarian Neoplasms
  • Proto-Oncogene Proteins p21(ras)

abstract

  • rs61764370 is not associated with risk of ovarian or breast cancer nor with clinical outcome for patients with these cancers. Therefore, genotyping this variant has no clinical utility related to the prediction or management of these cancers.

authors

publication date

  • May 2016

Research

keywords

  • Review

Identity

Language

  • eng

PubMed Central ID

  • PMC4630206

Digital Object Identifier (DOI)

  • 10.1016/j.ygyno.2015.04.034

PubMed ID

  • 25940428

Additional Document Info

start page

  • 386

end page

  • 401

volume

  • 141

number

  • 2